Chelation and Ozone Combination ? the knock-out blow in treating ischemic heart disease [abstract]

2018

The recent TACT study published in the Journal of the American Medical Association showed that up to 50% of selected patients with heart disease will die from their disease unless they are treated with EDTA chelation therapy. Special benefits are seen in the diabetic population. TACT 2 is now underway to better understand the mechanisms at play to bring about this outcome. (Lamas, G. A., Goertz, C., Boineau, R., Mark, D. B., Rozema, T., Nahin, R. L., et al. (2013). Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial. JAMA, 309(12), 1241?1250). Now a new study is offering proof that not only can EDTA ch…